|Articles|November 12, 2018
SAS Adds Artificial Intelligence to Trial Data, RWE
Advertisement
SAS’ next-generation solutions for clinical trial data analysis and real world evidence debuted at PhUSE EU Connect in Frankfurt, Germany. This debut introduced SAS Life Science Analytics Framework and SAS Real World Evidence to help improve the development and safety of new pharmaceuticals with artificial intelligence.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
2
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
3
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
4
Driving Collaboration Across Functions to Streamline Drug Development
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
